Switching It Up A Bit: We Will Look At "The Littler Guys, First" -- Here At Year End -- On Lobbying Disclosures...

After the death penalty one, below -- I'll run a palate cleanser. . . on some of the drier, mid major year 2023 lobby spend data. For the full year, Baxter spent $1.54 million; Abbott's spend was over double that, at $3.86 million.

Here is how smaller Baxter (in blue) used its Q4 dollars, with its full year imaged (on a quarterly basis), as against slightly larger Abbott. We will drop Abbott's more detailed Q4 spend (in green) below Baxter's:

. . .Issues related to pharmaceutical pricing; Legislation to incentivize new technology for innovation in home dialysis (no current bill number). . . .

Issues relating to drug pricing, home dialysis expansion, ESRD reimbursement for Hemodialysis, 340B Drug pricing, device sterilization. Issues relating to safe mobility and issues relating to diabetic retinopathy. Issues relating to pandemic all-hazards preparedness act. H. Res. 550 and H.R. 4421. Issues related to artificial intelligence in healthcare. . . .

Issues related to increasing funding for Strategic National Stockpile. Labor, Health, and Human Services appropriations. . . .

Taxation of multinational companies. Monitor tax reform proposal relating to corporate tax policies. . . .

And. . . at Abbott Labs:

S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. S. 2922 Advancing Research for Chronic Pain Act of 2023. H.R. 2369 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021. Proposals related to sterilization of medical devices. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). Proposals related to digital health technologies and innovations. Proposals related to Department of Defense coverage of continuous glucose monitors. Proposals to advance policies related to effective pain management. Proposals related to testing for malaria. . . .

S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. H.R.3674 Providing Relief and Stability for Medicare Patients Act of 2023. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors. Proposals related to diagnostic testing coverage. . . .

Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance. Proposals related to preserving critical medical supply chains. Proposals regarding infant and child nutrition marketing. . . .

Proposals regarding the implementation and modernization of the WIC program. Proposals related to access to infant formula. . . .

Proposals related to VA coverage of continuous glucose monitors. . . .

Public Law 115-97 The Tax Cuts and Jobs Act. Public Law 117-169 Inflation Reduction Act of 2022. Proposals to reform domestic and international tax structures. . . .

H.R. 3108 Medical Nutrition Therapy Act of 2021. . . .

Proposals related to the shutdown of the United States Government. . . .

Proposals related to third party litigation reform. . . .

Now you know -- but pretty discouraged by the Alabama ruling, from Thomas. Onward -- just the same.

नमस्ते